OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.
OS Therapies has raised $7.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2026.
OS Therapies's investors include Noble Capital Markets, K20 Fund, Leonite Fund I, Square Gate Capital, Tichenor Ventures.
OS Therapies is headquartered in New York, United States.
OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.
OS Therapies is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OS Therapies — Funding & Investors." VCBacked, October 19, 2026, https://www.vcbacked.co/company/os-therapies. Accessed November 14, 2026.
VCBacked. (2026). OS Therapies — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/os-therapies
{{cite web |title=OS Therapies — Funding & Investors |url=https://www.vcbacked.co/company/os-therapies |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at OS Therapies? Request a listing update